These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 347330

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Pharmacologic study of nicergoline in the pathology of the cervico-prostatic sphincter].
    Ghaddar Y, Caissel J, Léandri P, Rossignol G.
    Ann Urol (Paris); 1987; 21(2):107-14. PubMed ID: 2441642
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Use of sermion in cerebral atherosclerosis patients with a history of ischemic stroke].
    Tsimenko OA, Sosnov IuD, Kharchenko AP, Gaĭduk IuS.
    Vrach Delo; 1988 Jul; (7):24-7. PubMed ID: 3188456
    [No Abstract] [Full Text] [Related]

  • 29. [Therapy of demonstrated cerebral ischemia with nicergoline (Sermion)].
    Karyofilis A.
    Ther Ggw; 1980 Dec; 119(12):1478-85. PubMed ID: 7466692
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
    Pohle W, Hirche H, Barmeyer J, Schümichen C, Hoffmann G.
    Med Welt; 1979 Feb 16; 30(7):269-72. PubMed ID: 372733
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Symptomatic treatment of benign prostatic obstruction with nicergoline: a placebo controlled clinical study and urodynamic evaluation.
    Ronchi F, Margonato A, Ceccardi R, Rigatti P, Rossini BM.
    Urol Res; 1982 Feb 16; 10(3):131-4. PubMed ID: 6182672
    [Abstract] [Full Text] [Related]

  • 34. [Trial of nicergoline in arteriopathies of the lower limbs (apropos of 33 cases)].
    Debaert M, Ribet M, Quandalle P.
    Lille Med; 1981 Mar 16; 26(3):140-3. PubMed ID: 7289750
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
    Friedman LM.
    Circulation; 1980 Dec 16; 62(6 Pt 2):V88-9. PubMed ID: 7002355
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Haemodynamic and metabolic effects of exercise test in diabetic patients with arteritis treated or not with nicergoline (author's transl)].
    Boismare F, Leclerc JL, Lefrançois J, Moore N, Paux G, Schrub JC, Vuillermet P.
    Sem Hop; 1980 Dec 16; 57(33-36):1455-7. PubMed ID: 6270809
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.